Skip to main content
. Author manuscript; available in PMC: 2023 Aug 11.
Published in final edited form as: Lancet. 2023 Mar 14;401(10384):1302–1312. doi: 10.1016/S0140-6736(23)00001-6

Table 2.

Criterion and rating scale for potential metrics of the Global Diabetes Compact.

Criterion Excellent Good Fair
Intrinsic health importance or strong evidence for prediction or benefit on major health outcomes. Major health outcome affecting QOL (e.g., MI, LEA). Biomarker or intervention with clear causal linkage to health outcome. Process, intervention, or factor with potential linkage.
Modifiable with scalable interventions targeting the metric. Clearly efficacious and scalable via evidence-based means. Moderately efficacious and scalable. Lacking clear scalability – or – clear health effect if scalable.
Strong global data availability with acceptable measurement properties. Currently available for 75% of countries. Currently available for 25 - 75% of countries. Available for fewer than 25% of countries.
International gap and disparity Large proportion of population affected and large international variation Large proportion of population affected – OR - large international variation Modest international gap or limited variation